Invesco Dorsey Wright Healthcare Momentum ETF Rating $40.13 +0.45 (+1.13%) As of 04/30/2025 03:59 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Dorsey Wright Healthcare Momentum ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PTH Aggregate RatingModerate Buy 2.86Holdings in PTH have an aggregate rating of Moderate Buy based on 380 analyst ratings issued in the past year covering 35 companies (99.7% of the portfolio).PTH Aggregate Price Target$40.13High Prediction$40.13Average Prediction$40.13Low Prediction$40.13Holdings in PTH have an aggregate price target of $40.13 and a range of $40.13 to $40.13 covering 35 companies (99.7% of the portfolio).PTH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright Healthcare Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 35 PTH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.60%CORCencora$292.76+0.9%4.2357 of 5 stars2.78$290.00 -0.9%9Upcoming EarningsAnalyst ForecastPositive News4.43%ALHCAlignment Healthcare$17.72+1.7%1.6506 of 5 stars2.67$16.61 -6.3%12Positive News4.03%EXELExelixis$39.15+1.6%4.0784 of 5 stars2.47$37.59 -4.0%19Short Interest ↑Analyst RevisionPositive News3.85%LLYEli Lilly and Company$899.78+1.6%4.9193 of 5 stars2.80$1,000.32 11.2%20Analyst Downgrade3.72%BSXBoston Scientific$102.90+0.2%4.4457 of 5 stars3.04$114.52 11.3%23Analyst Upgrade3.66%TGTXTG Therapeutics$45.51+3.8%3.3378 of 5 stars2.83$40.67 -10.6%6Upcoming EarningsPositive NewsGap Down3.53%KRYSKrystal Biotech$169.88-0.4%4.908 of 5 stars3.00$222.71 31.1%8Upcoming EarningsAnalyst ForecastNews CoveragePositive News3.41%MDGLMadrigal Pharmaceuticals$333.91-2.0%3.7505 of 5 stars3.00$409.00 22.5%9News CoveragePositive NewsGap Down3.39%GHGuardant Health$47.23-4.6%3.9526 of 5 stars3.05$49.00 3.7%21News CoverageGap Down3.31%BBIOBridgeBio Pharma$38.36+5.3%4.5498 of 5 stars2.92$57.09 48.8%12Earnings ReportAnalyst ForecastOptions VolumeNews CoverageHigh Trading Volume3.27%RMDResMed$236.49-0.5%3.917 of 5 stars2.60$258.83 9.4%15Dividend Announcement3.22%INSMInsmed$72.00+0.8%4.3491 of 5 stars3.00$94.00 30.6%16Upcoming EarningsPositive News3.18%AXSMAxsome Therapeutics$112.29+2.2%4.8386 of 5 stars3.00$169.87 51.3%16Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News3.16%MMSIMerit Medical Systems$94.45-0.3%3.9633 of 5 stars3.00$107.78 14.1%10Earnings ReportShort Interest ↑Analyst Revision3.15%ABBVAbbVie$195.15+0.8%4.6169 of 5 stars2.89$211.41 8.3%27Earnings ReportAnalyst ForecastAnalyst Revision3.14%AGLagilon health$4.26+12.1%1.6768 of 5 stars2.11$4.81 12.9%18Upcoming EarningsAnalyst ForecastNews Coverage3.08%LNTHLantheus$104.34+0.4%3.9823 of 5 stars3.00$129.43 24.0%7Upcoming EarningsPositive News2.73%PTGXProtagonist Therapeutics$45.82+0.4%3.4338 of 5 stars3.00$65.44 42.8%9Upcoming EarningsNews CoveragePositive News2.60%CPRXCatalyst Pharmaceuticals$24.29+0.0%4.6886 of 5 stars3.13$32.29 32.9%8Upcoming EarningsNews CoveragePositive News2.56%AXGNAxoGen$16.27-1.5%2.8864 of 5 stars3.00$22.60 38.9%5Upcoming EarningsPositive News2.54%MASIMasimo$160.96-1.3%3.7911 of 5 stars2.83$194.80 21.0%6Upcoming EarningsPositive News2.46%ARQTArcutis Biotherapeutics$14.91+1.1%2.7597 of 5 stars2.83$18.80 26.1%6Upcoming EarningsPositive NewsGap Down2.38%AMRXAmneal Pharmaceuticals$7.66-1.2%3.3621 of 5 stars3.00$10.80 41.0%5News CoveragePositive NewsHigh Trading Volume2.36%TRVITrevi Therapeutics$6.91+9.5%3.6034 of 5 stars3.30$17.56 154.2%10Upcoming EarningsNews CoveragePositive News2.32%PTCTPTC Therapeutics$49.84+0.6%4.0745 of 5 stars2.53$63.92 28.3%15Upcoming EarningsNews CoveragePositive News2.28%HALOHalozyme Therapeutics$61.42+1.0%3.9987 of 5 stars2.60$62.89 2.4%10Upcoming EarningsInsider TradeAnalyst Revision2.22%OCULOcular Therapeutix$8.30+1.1%3.4863 of 5 stars2.89$16.38 97.3%9Upcoming EarningsNews Coverage2.17%AVXLAnavex Life Sciences$9.50-1.3%3.8231 of 5 stars3.33$44.00 363.2%3Upcoming EarningsNews CoveragePositive News2.12%MASS908 Devices$5.43-0.7%1.1632 of 5 stars2.50$5.33 -1.8%4News Coverage1.90%XERSXeris Biopharma$4.57+3.6%3.6014 of 5 stars2.80$6.10 33.5%5Upcoming EarningsNews CoveragePositive News1.90%PHRPhreesia$24.95+0.4%3.9939 of 5 stars3.00$31.33 25.6%12Short Interest ↑1.86%LQDALiquidia$13.97+3.4%2.8519 of 5 stars3.11$26.63 90.6%9Positive News1.77%MLYSMineralys Therapeutics$14.21+1.9%2.3896 of 5 stars3.00$33.00 132.2%3Upcoming EarningsShort Interest ↑High Trading Volume1.74%ORGOOrganogenesis$4.91+0.6%3.4345 of 5 stars2.50$5.50 12.0%2Upcoming EarningsNews CoveragePositive News1.69%QUREuniQure$14.76+6.5%2.403 of 5 stars2.82$38.80 162.9%11Upcoming EarningsShort Interest ↑Analyst RevisionGap Down This page (NASDAQ:PTH) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright Healthcare Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Dorsey Wright Healthcare Momentum ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTH Stock Free PTH Stock Alerts